Oral corticosteroids (eg, prednisone) Beta2 -agonist and anticholinergic combinations (eg, ipratropium and albuterol, umeclidinium bromide/vilanterol inhaled) Beta2 -agonist and corticosteroid combinations (eg, budesonide/formoterol, fluticasone and salmeterol, vilanterol/fluticasone inhaled) Pulmonary rehabilit...
symptom severity, functional status, and well-being or overall health status; 20 pharmaceutical classes were trialed; 10 medications were shown to be slightly to moderately effective in their respective study groups (p < 0.05). The
A severe exacerbation was defined as a hospitalization with a primary diagnosis of COPD (using the same codes as above (see Study Cohort), with the exclusion of ICD-9-CM code 491.20, obstructive chronic bronchitis without exacerbation). A moderate COPD exacerbation was defined as a prednisone ...
The study has several limitations. The study population and all outcome definitions are based on ICD-9 CM and ICD-10 CM, not clinical diagnosis because the examination results and lab data are lack in NHIRD. Despite, we use many alternative definitions that combined diagnosis code with medication...
There are also spikes in testing and prescribing at time of incentive billing, but rates return to pre-period trends for all but a handful of care processes (HbA1c and lipid panels among diabetes patients, ACR and lipid panels testing hypertension patients, and prednisone dispensing among COPD ...
In a pooled analysis of 71 controlled clinical trials, a relative risk of 1.6 for infectious complications were reported in patients given more than a cumulative dose of >700 mg prednisone [12], but a stratified analysis of trials including patients with pulmonary diseases showed no increased ...
Oral corticosteroids (eg, prednisone) Beta2 -agonist and anticholinergic combinations (eg, ipratropium and albuterol, umeclidinium bromide/vilanterol inhaled) Beta2 -agonist and corticosteroid combinations (eg, budesonide/formoterol, fluticasone and salmeterol, vilanterol/fluticasone inhaled) Pulmonary rehabilit...
Oral corticosteroids (eg, prednisone) Beta2 -agonist and anticholinergic combinations (eg, ipratropium and albuterol, umeclidinium bromide/vilanterol inhaled) Beta2 -agonist and corticosteroid combinations (eg, budesonide/formoterol, fluticasone and salmeterol, vilanterol/fluticasone inhaled) Pulmonary rehabilit...
Exclusion of major immunosuppressing conditions or current use of immunosuppressant medications (including chemotherapy and corticosteroid use >7.5 mg prednisone/day for >3 months). Value of corticosteroid use >7.5 mg/day for >3 months was arbitrarily set by the authors as being above the minimum ...